PA
RVNC

Perceptive Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

Perceptive Advisors’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-600,000
Closed -$1.54M – 124
2024
Q2 		$1.54M Hold
600,000
– – 0.04% 96
2024
Q1 		$2.95M Buy
+600,000
New +$3.55M 0.05% 101
2023
Q1 		– Sell
-729,097
Closed -$13.5M – 109
2022
Q4 		$13.5M Sell
729,097
-79,574
-10% -$1.82M 0.38% 53
2022
Q3 		$21.8M Buy
808,671
+236,157
+41% +$4.79M 0.63% 42
2022
Q2 		$7.91M Buy
572,514
+435,000
+316% +$6.7M 0.25% 69
2022
Q1 		$2.68M Buy
+137,514
New +$2.09M 0.05% 114
2020
Q3 		– Sell
-65,839
Closed -$1.61M – 144
2020
Q2 		$1.61M Sell
65,839
-859,161
-93% -$17M 0.03% 106
2020
Q1 		$13.7M Buy
925,000
+104,623
+13% +$2.16M 0.36% 52
2019
Q4 		$13.3M Buy
+820,377
New +$12.7M 0.26% 57
2018
Q2 		– Sell
-618,957
Closed -$19.1M – 151
2018
Q1 		$19.1M Buy
618,957
+218,957
+55% +$7.04M 0.53% 47
2017
Q4 		$14.3M Buy
+400,000
New +$11.5M 0.47% 49

Other funds holding RVNC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Perceptive Advisors's RVNC Position: Q3 2024 in Review

Perceptive Advisors sold out of Revance Therapeutics, Inc. (RVNC) in Q3 2024, closing a stake of 600,000 shares — an estimated $1.54M sold.

Perceptive Advisors first reported a position in RVNC in Q4 2017 and held it in 11 quarters. The position peaked at $21.8M in Q3 2022. 201 funds tracked by Wall St. Rank hold RVNC as of Q3 2024.

  • Perceptive Advisors reported no remaining Revance Therapeutics, Inc. position as of Q3 2024 after selling out during the quarter.
  • Perceptive Advisors sold 600,000 Revance Therapeutics, Inc. shares in Q3 2024, an estimated $1.54M.
  • Perceptive Advisors first reported a position in Revance Therapeutics, Inc. in Q4 2017 and held it in 11 quarters.
  • Perceptive Advisors's Revance Therapeutics, Inc. position peaked at $21.8M in Q3 2022.
  • 201 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q3 2024.

Based on Perceptive Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.